241 related articles for article (PubMed ID: 31096984)
1. Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs.
Kim K; Yoo D; Lee HS; Lee KJ; Park SB; Kim C; Jo JH; Jung DE; Song SY
BMC Med Genomics; 2019 May; 12(1):62. PubMed ID: 31096984
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers.
Kojima M; Sudo H; Kawauchi J; Takizawa S; Kondou S; Nobumasa H; Ochiai A
PLoS One; 2015; 10(2):e0118220. PubMed ID: 25706130
[TBL] [Abstract][Full Text] [Related]
3. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
4. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
5. Real-time PCR-based analysis of the human bile microRNAome identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer.
Shigehara K; Yokomuro S; Ishibashi O; Mizuguchi Y; Arima Y; Kawahigashi Y; Kanda T; Akagi I; Tajiri T; Yoshida H; Takizawa T; Uchida E
PLoS One; 2011; 6(8):e23584. PubMed ID: 21858175
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
[TBL] [Abstract][Full Text] [Related]
7. Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.
Høgdall D; O'Rourke CJ; Larsen FO; Zarforoushan S; Christensen TD; Ghazal A; Boisen MK; Muñoz-Garrido P; Johansen JS; Andersen JB
J Hepatol; 2022 Oct; 77(4):1047-1058. PubMed ID: 35750139
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter study.
Cao Z; Liu C; Xu J; You L; Wang C; Lou W; Sun B; Miao Y; Liu X; Wang X; Zhang T; Zhao Y
Oncotarget; 2016 Jul; 7(27):41575-41583. PubMed ID: 27223429
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.
Kishimoto T; Eguchi H; Nagano H; Kobayashi S; Akita H; Hama N; Wada H; Kawamoto K; Tomokuni A; Tomimaru Y; Umeshita K; Doki Y; Mori M
Cancer Sci; 2013 Dec; 104(12):1626-31. PubMed ID: 24118467
[TBL] [Abstract][Full Text] [Related]
11. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
13. Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.
Hua Y; Chen H; Wang L; Wang F; Wang P; Ning Z; Li Y; Liu L; Chen Z; Meng Z
Cancer Biomark; 2017 Jul; 20(1):95-100. PubMed ID: 28759959
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of bile-derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers.
Yoshida M; Yukawa H; Hayashi K; Naitoh I; Miyabe K; Hori Y; Natsume M; Jinno N; Kato A; Kachi K; Asano G; Sahashi H; Toyohara T; Kuno K; Kito Y; Kondo H; Hirano A; Okumura F; Anbe K; Baba Y; Kataoka H; Tanaka Y
Cancer Sci; 2023 Jan; 114(1):295-305. PubMed ID: 36168845
[TBL] [Abstract][Full Text] [Related]
15. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
16. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
17. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
[TBL] [Abstract][Full Text] [Related]
18. miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Alemar B; Izetti P; Gregório C; Macedo GS; Castro MA; Osvaldt AB; Matte U; Ashton-Prolla P
Pancreas; 2016 Jan; 45(1):84-92. PubMed ID: 26262588
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of quantitative analysis of microRNA in bile samples obtained during endoscopic retrograde cholangiopancreatography for malignant biliary strictures.
Kuniyoshi N; Imazu H; Masuzaki R; Yamazaki M; Hamana S; Nomura S; Hayama J; Osawa R; Yamada K; Fujisawa M; Saito K; Kogure H
PLoS One; 2023; 18(8):e0289537. PubMed ID: 37561751
[TBL] [Abstract][Full Text] [Related]
20. Identification of Circulating Serum miRNAs as Novel Biomarkers in Pancreatic Cancer Using a Penalized Algorithm.
Lee J; Lee HS; Park SB; Kim C; Kim K; Jung DE; Song SY
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]